We could not find any results for:
Make sure your spelling is correct or try broadening your search.
IQVIA Holdings Inc is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceuti... IQVIA Holdings Inc is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business. Show more
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024. The IQVIA management team will also host a...
IQVIA (NYSE:IQV), a leading global provider of data, analytics, technology and services to the life sciences industry, and Salesforce (NYSE:CRM), the #1 AI CRM, today announced an expanded global...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays 26th Annual Global Healthcare...
IQVIA™ (NYSE:IQV), has published its 2023 Environmental, Social and Governance (ESG) Report. The annual report provides a detailed account of the organization’s focus on reducing its...
Clinical development productivity rose in 2023, primarily due to an improvement in the composite success rate, a function of phases successfully completed in the year, which rose to 10.8%. This...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at Citi’s 2024 Unplugged Medtech and Life Sciences...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 7.34 | 3.22580645161 | 227.54 | 244.27 | 225.54 | 1038330 | 235.70898787 | CS |
4 | -18.45 | -7.28299056567 | 253.33 | 253.84 | 222.71 | 801605 | 237.04849613 | CS |
12 | 25.32 | 12.0824584844 | 209.56 | 261.73 | 208.05 | 953771 | 240.68686955 | CS |
26 | 53.66 | 29.6104182761 | 181.22 | 261.73 | 167.42 | 1095007 | 221.54513276 | CS |
52 | 44.75 | 23.536527639 | 190.13 | 261.73 | 167.42 | 1099210 | 213.50572503 | CS |
156 | 1.79 | 0.767943712729 | 233.09 | 285.61 | 165.75 | 1015333 | 221.48192577 | CS |
260 | 97.5 | 70.9710292619 | 137.38 | 285.61 | 81.79 | 1110316 | 189.71722089 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions